美国的关税可能导致药品短缺和价格上涨,警告Novo Nordisk医疗保健公司。 
U.S. tariffs may cause drug shortages and price increases, warns healthcare firm Novo Nordisk.
一家大型医疗保健公司Novo Nordisk警告说,美国关税可能导致药品短缺和价格上涨,特别是非专利药品。 Novo Nordisk, a major healthcare company, warns that U.S. tariffs could lead to drug shortages and price hikes, especially for generic medicines. Lars Fruergaard Jørgensen首席执行官指出,该公司在国际上提供关键成份,而关税可能会打乱这一点,从而增加成本。 CEO Lars Fruergaard Jørgensen notes that the company sources key ingredients internationally, and tariffs could disrupt this, raising costs. 该公司正在美国设施投资,但警告说,关税仍然可能影响药品价格和供应。 The company is investing in U.S. facilities but warns that tariffs could still impact drug prices and availability.
